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Background: Major depression is a disabling psychiatric illness with complex origins. Life stress (childhood
adversity and recent stressful events) is a robust risk factor for depression. The relationship between life stress and
Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene has received much attention.
The aim of the present work was to review and conduct a meta-analysis on the results from published studies
examining this interaction.
Methods: A literature search was conducted using PsychINFO and PubMed databases until 22 November 2013. A
total of 22 studies with a pooled total of 14,233 participants met the inclusion criteria, the results of which were
combined and a meta-analysis performed using the Liptak-Stouffer z-score method.
Results: The results suggest that the Met allele of BDNF Val66Met significantly moderates the relationship between
life stress and depression (P = 0.03). When the studies were stratified by type of environmental stressor, the
evidence was stronger for an interaction with stressful life events (P = 0.01) and weaker for interaction of BDNF
Val66Met with childhood adversity (P = 0.051).
Conclusions: The interaction between BDNF and life stress in depression is stronger for stressful life events rather
than childhood adversity. Methodological limitations of existing studies include poor measurement of life stress.
Keywords: Stress, Life events, Childhood maltreatment, Childhood adversity, Child abuse, Depression, Brain-derived
neurotrophic factor, BDNF, rs6265, Gene-environment interactionBackground
Major depression is a prevalent psychiatric illness that is
associated with considerable morbidity and mortality [1].
Much research has been dedicated to uncovering its
aetiology with mixed success. Environmental factors,
such as childhood adversity [2,3] and stressful life events
[4-6] have been associated with the onset and course of
major depression. However, not everyone exposed to such
adversity develops this illness or relapses [6]; this has led re-
searchers to explore stress vulnerability factors, including
interactions with genetic influences [7]. The brain-derived* Correspondence: g.hosang@gold.ac.uk
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reproduction in any medium, provided the orneurotrophic factor (BDNF) gene has been implicated in
stress vulnerability [8]. Both variation in this gene sequence
and stress exposure influence expression and intracellular
trafficking of the BDNF protein. Stress is hypothesised to
cause a reduction in BDNF (protein) levels in the brain
(particularly in regions linked to emotion), which alters
mood and may cause depression [9]. Consequently, the
BDNF gene has been identified as a stress vulnerability
candidate generating much research, which has yet to
be reviewed or synthesised.
The purpose of the present work was to systematically
review and perform a meta-analysis on studies that
have investigated the interaction between the Val66-
Met polymorphism in the BDNF gene and life stress
(childhood adversity and stressful life events) in depression.
Major depression has a lifetime prevalence of 17% [10]
and is diagnosed based on the presentation of depressivel Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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suicidal behaviours) that last at least 2 weeks [1]. Depressive
episodes are also experienced by individuals suffering
from bipolar disorder, although the defining feature of this
condition is mania (symptoms include, elation, grandiosity
and irritability) [11].
Major depression is considered one of the most burden-
some diseases in the world [12] and it is projected that this
illness will be the second leading cause of disease burden
for developed countries by 2020 [13]. Better understanding
of the aetiology of this debilitating disorder is urgently
required so that steps can be taken to reduce the burden
on the individual, their families and society as a whole.
Life stress and depression
There is a wealth of literature concerned with the im-
pact of life stress and depression, with studies focusing
on childhood adversity and stressful life events.
Childhood adversity
Childhood adversity is defined as stressful experiences
that occur early in life; examples include abuse (such as
sexual and physical abuse), neglect (failure of caretakers to
provide the child with basic needs such as food or support),
parental death and divorce. Significantly higher rates
of childhood adversity are reported by adults with
major depression compared to the general population [14].
Childhood adversity is also associated with worse course of
depression, including lack of treatment response as well as
more chronic and more frequent episodes [15].
Most studies in this area rely on retrospective reporting
which is associated with various biases calling into question
the validity and reliability of their findings. A recent study
showed that whether childhood maltreatment is assessed
prospectively (child protection database) or retrospectively
(self-report), it is still significantly associated with major
depression to a similar degree [16]. Moreover, Widom and
colleagues [17] prospectively followed children who were
abused or neglected (identified through court records), and
found that as adults these individuals were at increased risk
of major depression compared to matched controls.
Childhood adversity is a non-specific risk factor and has
been linked to other emotional problems [18], psychiatric
illnesses [16,19,20] and physical disorders [21,22]. A better
understanding of the specific mechanisms that underlie
the childhood adversity/depression association is needed.
Stressful life events
Stressful life events are described as circumstances that have
a negative impact on an individual (for example, stress)
that occur close to the onset or relapse of the illness
[23]. Stressful events such as bereavement and divorce
are common, but people’s responses to such events
vary, some appear to cope well and others spiral into adepressive episode [6,24]. Although it has been shown
that stressful life events cluster before a depressive epi-
sode or worsening of symptoms [4,25], there is strong
evidence that one such event is sufficient to trigger an
episode onset [26].
Investigating the relationship between stressful events
and depression is not as straightforward as establishing
whether an event occurred or not, various elements must
be considered. Determining the direction of association is
important, are stressful events generated by the individual
and influenced by depressive symptoms (dependent events),
or is it that such events occur ‘out of blue’ and trigger
depressive episodes (independent events)? Establishing
the event severity is essential as their impact differs be-
tween individuals and is dependent on circumstance.
These key issues are addressed with the collection of con-
textual and biographical information best achieved using
semi structured interviews [27-29]. Studies employing
this method have consistently shown that severe inde-
pendent events are linked to the onset, relapse and ex-
acerbation of depressive symptoms [5,25,30], illustrating
a causal relationship.
There is strong evidence for an association between
life stress and depression, research now focuses on iden-
tifying stress vulnerability factors in depression including
genetic factors [31,32].
Gene/environment interactions
Genetic sensitivity to one’s environment or gene-
environment interactions [33], has spurred much mental
health research following Caspi and colleagues’ [31] study.
Their results showed that the low expressing short allele
of the serotonin-transporter-linked promoter region poly-
morphism (5-HTTLPR; a functional variant in the serotonin
transporter gene) increased depressive symptoms, rates of
diagnosed depression and suicidality following exposure to
stressful events and childhood maltreatment [31].
Many studies that attempted to replicate these results
adopted different designs using divergent samples/
populations, which resulted in mixed success [34,35].
The reviews [7,28,36] and meta-analytic studies [15,37]
published on this topic suggest that the interaction is
strongest between 5-HTTLPR and childhood adversity,
rather than recent stressful events [37]. Life stress assess-
ment is crucial, with studies that used objective measures
or semi structured interviews rather than crude self-
report questionnaires detecting the interaction with the 5-
HTTLPR variant [37]. The relationship between life stress
and the serotonin transporter gene is fairly consistent for
persistent and recurrent depression [14,38,39].
Other genes have been implicated in stress vulnerability
including the CRHR1 [40,41], FKBP5 [42] and BDNF [43]
genes. The relationship between the Val66Met variant in
the BDNF gene and stress in depression has been widely
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is warranted to synthesise the literature.
BDNF and life stress in depression
BDNF is a protein involved in the proliferation, differ-
entiation and survival of neuronal cells and regulation
of synaptic plasticity and connectivity in the adult brain
[44]. Research suggests that BDNF may also be influential
in sensitivity to stress.
According to the ‘neurotrophic hypothesis’ of de-
pression [8,45], stress reduces BDNF activity, which
results in decreased function in limbic brain regions
(for example, hippocampus) involved in emotion processing
and cognition. This reduction in turn is posited to be
associated with depressed mood; while antidepressant
therapy is hypothesised to reverse this effect [9,45].
There is evidence that stress and trauma result in de-
creased BDNF levels in both rodents [46,47] and humans
[48,49]. The findings from several meta-analyses show
that lower serum BDNF levels are detected among de-
pressed patients relative to controls but these levels
are normalised with antidepressant treatment [50,51].
There is some debate surrounding the link between
BDNF, antidepressants and (hippocampal) neurogenesis
(see [52] for more a detailed discussion). Together the
evidence presented generally supports the ‘neurotrophic
hypothesis’ of depression.
A single nucleotide polymorphism (SNP) in the BDNF
gene (that is, Val66Met; rs6265) has been shown to in-
fluence the activity of the BDNF protein. This SNP re-
sults in the substitution of valine (Val) to methionine
(Met) [53]. Although the BDNF gene consists of several
polymorphisms many are in high linkage disequilibrium
and highly correlated [54,55].
The Met allele of the BDNF Val66Met polymorphism
has been linked with reduced BDNF activity [44], memory
impairment [56] and harm avoidance [57]. Individuals with
at least one Met allele of this SNP and at high risk of
affective disorders (co-twin diagnosed with a mood disorder)
have elevated evening cortisol levels, which suggests altered
stress response [58].
Transgenic mice that are Met carriers of BDNF Val66-
Met exhibit increased anxiety-related behaviours under
stress conditions [59], as well as decreased BDNF levels
in the hippocampus [60], in line with the ‘neurotrophic
hypothesis’.
The research highlighted thus far presents a case for a
significant interaction between BDNF Val66Met and
life stress in depression. The purpose of the current
paper is to systematically review and meta-analyse the
literature concerned with this interaction addressing
the specific question: ‘is there a significant interaction
between the Met variant of BDNF Val66Met and life
stress in depression?’Methods
Data sources and search strategy
The systematic review was performed according to the
‘Preferred Reporting Items for Systematic Reviews and
Meta-Analyses’ (PRISMA) guidelines [61]. The literature
searches were undertaken using PsychINFO, and PubMed
up until 22 November 2013 for original research studies.
The search terms were synonyms for depression, life stress
and the BDNF Val66Met polymorphism (see Table 1).
These terms were searched for in the articles’ titles,
keywords, tests and measures. Only papers published
in the English language were considered for inclusion. The
reference lists of identified studies were also searched by
hand for relevant papers.
Eligibility criteria
The eligibility criteria were stipulated as follows: utilisation
of human participants; depression (illness onset or relapse)
or its symptoms were assessed; focus on BDNF Val66Met
polymorphism (rs6265); childhood adversity and/or
stressful life events (a range of types of events) were
assessed; the interaction between stress and the BDNF
Val66Met polymorphism was investigated. Studies in
gross departure of Hardy-Weinberg equilibrium were
excluded (for example, P ≤0.001).
Data extraction
Variety of data were extracted from included studies in
accordance with other gene-environment interaction re-
views [37,62] (see Table 2). When publications reported
results for both childhood adversity and recent stressful life
events they were included in each environmental stressor
group; but the results for each stressor were averaged and
included in the overall analyses. The data was extracted
and confirmed by two authors (GMH and KET). Where
studies used multiple life stress and/or depression
measures, the data yielded from interviews was in-
cluded in the analyses. If the information required was
not reported or unclear the authors of the original art-
icle were contacted.
Quality appraisal of studies
The methodological quality of included studies was evalu-
ated against a quality checklist, derived from the STREGA
(‘Strengthening the Reporting of Genetic Association
Studies’) and STROBE (‘Strengthening the Reporting of
Observational Studies in Epidemiology’) checklists [63,64],
which have been used by other gene-environment inter-
action meta-analyses [37].
In accordance with current guidelines and previous re-
views of gene-environment interaction studies [37], the
studies were not weighted by quality scores or excluded
based on low scores, but the information is presented in
Additional file 1 for readers’ evaluation.
Table 1 Terms used for literature search
Keyword(s) Additional search terms used
1. Depression Depressive disorder OR major depressive
disorder OR depression OR major depression OR
unipolar depression OR depressive symptoms
2. Life stress Stressful life events, OR life events OR negative
life events OR adverse life events OR events OR
stress OR stressors OR childhood maltreatment
OR childhood adversity OR childhood stress OR
child abuse OR child neglect OR adversity
3. BDNF Val66Met
polymorphism
Brain-derived neurotrophic factor gene OR BDNF
OR rs6265 OR Val66Met
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The Liptak-Stouffer z-score method was used to combine
studies at the level of significance tests with the results
weighted by sample size. This approach has been used by
another meta-analysis of gene-environment interactions
[37]. This method involves a number of steps. First, the
P values from the eligible studies were extracted and
converted to one-tailed values, with those less than
0.50 indicating greater Met allele stress sensitivity and
P values of greater than 0.50 corresponding to Val allele
stress sensitivity in depression. Second, these P values were
transformed into z-scores using a standard normal curve.
Positive z-scores were assigned to P <0.50 and negative
z-scores corresponded to P >0.50. Third, the z-scores were
combined and weighted to take into account the study
sample size. The following formula was used to do this:
Zw ¼
Xk
i¼1wiziﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃXk
i¼1w
2
i
q
The weighting factor wi corresponds to each study’s
sample size, k indicates the number of total studies, and
Zi corresponds to the z-scores of individual studies. Zw,
which is the outcome of this test, follows a standard nor-
mal distribution and thus related probability corresponds
with a standard normal distribution table. This approach
was used on the overall and stratified analyses.
Sensitivity analyses were undertaken to determine
whether the results were considerably influenced by
any single study; the procedure involved systematically
excluding each study and recalculating the significance
of the result.
To assess the potential impact of publication bias on
the meta-analysis results the fail-safe N was calculated
for all analyses. In line with Karg and colleagues [37],
the number of studies with a P value equal to 0.50 and
a sample size of 647 (average sample size of the studies
analysed in the overall meta-analysis) were calculated that
would need to be included in the weighted Liptak-Stouffer
analyses to obtain a non-significant result. The ratiobetween the fail-safe and the actual number of studies
published provides an estimation of the possibility of
publication bias effecting our findings.
Results
Study selection
A combination of the predefined search terms (depression +
life stress +BDNF Val66Met) resulted in 1,019 hits; after du-
plicates were removed, 236 studies remained (see Figure 1).
The abstracts of these articles were reviewed and those
studies that reported on the interaction between life stress
and BDNF Val66Met in depression were included. No
existing systematic or meta-analytic reviews were found.
Overall evidence for BDNF × stress in mood disorders
Out of the 22 studies included, 8 reported a significant
interaction between life stress (either life events or child
adversity) and the Met variant of BDNF Val66Met in
depression (see Table 2 and Figure 2).
Other studies provided partial evidence of a signifi-
cant stress × BDNF for specific types of depression [65],
childhood adversity [66,67] or detected a gender specific
effect [68].
Several studies found a significant interaction between
life stress and BDNF in depression using a Val recessive
model [69-71]. The allele frequencies of the BDNF
Val66Met polymorphism differs between ethnic groups,
with the Met allele frequency highest among Asian pop-
ulations [72]. Two of these studies used either a Han
Chinese sample [69], or a cohort with mixed ethnicity
[71], which may have contributed to the unusual finding
with a Val recessive model.
Meta-analysis result
Combining the results from the identified studies with a
total of 14,233 participants showed that the interaction
between the Met variant of the BDNF Val66Met poly-
morphism significantly moderates the relationship between
life stress and depression (P = 0.03). When findings from
studies that used Caucasian samples were meta-analysed
separately (to account for the potential confounding effect
of population stratification), the results failed to reach
conventional level of significance although they were
in the expected direction (P = 0.07).
The sensitivity analyses showed that the results
remained significant after removing each study in turn
(>0.004 P <0.049) with the exception of 4 studies
[43,73-75]. In terms of publication bias, to make these
results non-significant (P = 0.05), more than 11 unpub-
lished or undiscovered studies with an average sample
of 657 participants reporting a non-significant finding
(P = 0.50) would need to exist. This corresponds to a fail-
safe ratio of 2 studies not included in the meta-analysis for
every included study.
Table 2 Summary of studies examining the interaction between life stress and brain-derived neurotrophic factor (BDNF) Val66Met in depression
Source N Females,% Age at study
assessment
(Mean or range)
Ancestry Study design Stressor Life stress assessment Outcome Averaged
one-sided
P value
Kaufman et al., 2006 [79] 194 51 9.3 years Mixed Cross-sectional Childhood adversity Children taken into care Depressive symptoms 0.6765
Kim et al., 2007 [43] 732 59 65 years and over East Asian Cross-sectional Stressful life events Researcher-administered
questionnaire
Depression diagnosis 0.000315
Wichers et al., 2008 [73] 464 100 18 to 46 years European Longitudinal twin study Childhood adversity Questionnaire Depressive symptoms 0.009
Aguilera et al., 2009 [66] 470 55 22.9 years European Cross-sectional Childhood adversity Questionnaire Depressive symptoms 0.637
Bukh et al., 2009 [82] 290 66 38.5 years (median) European Case only Stressful life events Interview Depression onset 0.004
Gatt et al., 2009 [88] 374 51 36.2 years European Cross-sectional Childhood adversity Questionnaire Depressive symptoms 0.272
Hosang et al., 2010 [75] 1,085 62 37.83 years European Case–control Stressful life events Researcher-administered
questionnaire
Bipolar disorder relapse 0.02
Lavebratt et al., 2010 [68] 950 58 20 to 64 years European Longitudinal survey Childhood adversity
and Stressful life events
Questionnaire Depressive diagnosis 0.5
Nederhof et al., 2010 [80] 1,096 53 16.13 years European Longitudinal study Childhood adversity Questionnaires
and interviews
Depressive symptoms 0.3525
Carver et al., 2011 [76] 133 74 18.71 years Mixed Cross-sectional Childhood adversity Questionnaire Depression diagnosis 0.01
Elzinga et al., 2011 [81] 1,435 69 42.2 years European Case only Childhood adversity
and stressful life events
Interview Depression diagnosis
and symptom severity
0.4325
Juhasz et al., 2011 [74] 1,269 70 34.04 years Caucasian Cross-sectional Childhood adversity
and stressful life events
Questionnaire Depression diagnosis 0.13165
Chen et al., 2012 [69]a 780 51 13.6 years Han Chinese Longitudinal twin study Stressful life events Questionnaire Depressive symptoms 0.9875
Grabe et al., 2012 [70]a 2,035 53 55.6 years Caucasian Case only Childhood adversity Questionnaire Depressive symptoms 0.785
Herbert et al., 2012 [83] 279 100 36.8 years Caucasian Longitudinal study Stressful life events Interview Depression diagnosis 0.0935
Perea et al., 2012 [77] 302 50 18 years Mixed
(Columbian
population)
Cross-sectional Childhood adversity
and stressful life events
Questionnaire Depressive symptoms 0.01725
Quinn et al., 2012 [65] 240 59 40.01 years Unknown Cross-sectional Childhood adversity Questionnaire Melancholic subtype of
depression diagnosis
0.5
Caldwell et al., 2013 [71]a 124 66 21.97 years Mixed Cross-sectional Childhood adversity Questionnaire Depressive symptoms 0.8705
Comasco et al., 2013 [67] 1,393 50 17 to 18 years European Cross-sectional Childhood adversity Questionnaire Depressive symptoms 0.251
La Greca et al., 2013 [78] 116 54 8.85 years Mixed Cross-sectional Childhood adversity Questionnaire Depressive symptoms 0.167833
Jiang et al., 2013 [89]a 238 73 61.7 years Caucasians Cross-sectional Stressful life events Carer of person
with dementia
Depressive symptoms 0.9805
Brown et al., 2013 [85] 234 100 37 years Caucasian Longitudinal study Childhood adversity
and stressful life events
Interview Depressive episode onset 0.431
Total 14,233
Average sample size 647 0.03
aTested Val recessive model.
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Figure 1 Flow diagram of studies considered for inclusion. This flow diagram depicts each step in the process of study selection.
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effect with child adversity and stressful life events with
other SNPs (for example, 5-HTTLPR [43]), the results
pertaining to the impact of these types of stressors and
the BDNF gene were examined.Figure 2 Forest plot for included studies examining the interaction b
(BDNF) gene and life stress in depression.Childhood adversity
In all, 16 studies explored the interaction between childhood
adversity and BDNF in depression, 4 reported a significant
effect [73,74,76,77] and 5 showed partial support for this
interaction [65-68,78] (see Table 3).etween the Met variant of the brain-derived neurotrophic factor
Table 3 Studies included in the childhood adversity
meta-analysis
Source Sample size One-sided P value
Kaufman et al., 2006 [79] 194 0.6765
Wichers et al., 2008 [73] 464 0.009
Aguilera et al., 2009 [66] 470 0.637
Gatt et al., 2009 [88] 374 0.272
Lavebratt et al., 2010 [68] 642 0.5
Nederhof et al., 2010 [80] 1,096 0.3525
Carver et al., 2011 [76] 133 0.01
Juhasz et al., 2011 [74] 1,269 0.0018
Elzinga et al., 2011 [81] 1,435 0.435
Grabe et al., 2012 [70] 2,035 0.785
Quinn et al., 2012 [65] 240 0.5
Perea et al., 2012 [77] 302 0.016
La Greca et al., 2013 [78] 116 0.167833
Caldwell et al., 2013 [71] 124 0.8705
Comasco et al., 2013 [67] 1,393 0.251
Brown et al., 2013 [85] 234 0.431
Total 10,521
Average sample size 658 0.051
Table 4 Studies included in the stressful life events
meta-analysis
Source Sample size One-sided P value
Kim et al., 2007 [43] 732 0.000315
Bukh et al., 2009 [82] 290 0.004
Hosang et al., 2010 [75] 1,085 0.02
Lavebratt et al., 2010 [68] 950 0.5
Juhasz et al., 2011 [74] 1,269 0.2615
Elzinga et al., 2011 [81] 1,435 0.43
Chen et al., 2012 [69] 780 0.9875
Perea et al., 2012 [77] 302 0.0185
Herbert et al., 2012 [83] 279 0.0935
Jiang et al., 2013 [89] 238 0.9805
Brown et al., 2013 [85] 234 0.0004
Total 7,594
Average sample size 690 0.01
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as one overarching construct, Aguilera and colleagues [66]
focused on different types and only found a significant
interaction between child sexual abuse and BDNF.
Given the acknowledged heterogeneity in major depression
[1], Quinn and associates [65] explored the impact of
the child adversity-BDNF interaction on different sub-
types of the disorder and found a significant effect for
non-melancholic depression only.
The childhood adversity measures used by studies is
particularly noteworthy, with all of the those reporting a
significant interaction relying on questionnaires, while
many of those studies not reporting an effect utilised more
objective methods [79-81].
Childhood adversity: meta-analysis results
In meta-analysing the results from included studies with
a combined sample of 10,521 individuals, a trend towards
a significant interaction between childhood adversity and
BDNF in depression was detected (P = 0.051), but was not
improved on when only those studies with Caucasian
samples were analysed (P = 0.08).
In undertaking sensitivity analyses, the results remained
non-significant after removing each study in turn (>0.052
P <0.27), with the exception of 6 [66,68,70,71,79,81].
Stressful life events
The stressful events-BDNF interaction in depression
was investigated in 11 studies using a combined sampleof 7,594 individuals; 5 uncovered a significant effect
(see Table 4). The majority of these studies used either
researcher-administered questionnaires [43,75] or in-
terviews [82], while the non-replicating studies relied
on self-report checklists with one exception [83].
Bipolar disorder was the focus of one study [75], which
found that the effect of stressful life events on episodes
of bipolar depression were significantly greater in Met allele
carriers (Met/Met and Val/Met) relative to those with the
Val/Val genotype. However, no such pattern was reported
for manic episodes [75].
Stressful life events: meta-analysis results
A significant interaction between stressful life events and
the Met variant of BDNF Val66Met (P = 0.01) was found;
the results remained significant when the analyses were
restricted to studies using Caucasian samples (P = 0.027).
Sensitivity analysis showed the P value remained signifi-
cant with the exclusion of each study from the analysis
(>0.001 P <0.023), except for 2 [43,75].
For this result to be non-significant (P = 0.05) more
than 14 unpublished or unidentified studies need to
exist with an average sample of 690 participants and a
non-significant result (P = 0.50). This corresponds to a
fail-safe ratio of 1 study not included for every study
entered into the meta-analysis.
Discussion
A total of 22 studies with a combined sample of 14,233
participants met the eligibility criteria, 8 of which reported
a significant interaction between life stress and the Met
variant of BDNF Val66Met. The overall meta-analysis
found evidence for a significant interaction between life
stress and BDNF in depression using a Met dominant
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sor, the results were strongest for stressful life events while
the effect of childhood adversity failed to reach conven-
tional levels of significance.
These findings help build a lifespan model of causation
for major depression focusing on several gene-stress
interactions. Research shows that childhood adversity
(distal and stable risk factor) significantly interacts with the
short allele of the 5-HTTLPR [37], while the findings from
this meta-analysis suggest that the stressful life events
(proximal and provoking factor) significantly interacts
with the Met variant of BDNF in depression.
It has also been postulated that individuals who are
genetically sensitivity to adverse experiences (for example,
Met carriers) may benefit most from positive environments
or even the lack of adversity, under the ‘differentially
susceptibility’ hypothesis [84]. One study [85] found that
the likelihood of experiencing a depressive episode was
significantly reduced among individuals with at least one
Met allele of BDNF but only in the absence of a severe
stressful event. It is possible that interventions that focus
on providing supportive and positive environments would
be most beneficial to individuals who are genetically sensi-
tivity to stress.
The aetiology of psychiatric disorders such as major
depression is complex and is likely to involve multiple
interactions between genetic variants and environmental
factors. Few studies have explored the three-way inter-
action between childhood adversity, stressful life events
and stress vulnerability genetic variants [86]. A wealth of
research shows that adversity in childhood sensitises in-
dividuals to adult stressful life events increasing their
risk for major depression [87]. Given the mounting evi-
dence that genetic variants such as BDNF Val66Met
polymorphism are important stress vulnerability factors sets
the stage for future studies that should explore the child-
hood adversity × stressful life events × BDNF interaction in
the context of depression.
Child adversity
When examining the specific influence of child adver-
sity, 4 out of 16 studies reported a significant interaction
with BDNF Val66Met for depression, and 5 were able to
provide partial support for this interaction [65-68]. How-
ever, the results from the meta-analysis of these studies
provided only a trend towards a significant effect.
On closer inspection of these results it appears that the
childhood adversity-BDNF relationship in depression may
be complex, with some studies reporting a significant inter-
action among women and not men [68,73], and for specific
subtypes of depression (non-melancholic) [65]. In addition,
specific forms of childhood adversity maybe driving these
associations (for example, child sexual abuse [66]). More re-
search in this area is warranted focusing on specific formsof adversity and depression subtypes as well as investigating
gender differences.
The non-replicating studies have two characteristics
that are noteworthy. Firstly, some studies which failed to
detect any evidence for a child adversity × BDNF in
depression used child and adolescent cohorts [79,80].
Secondly, more reliable (for example, interviews [80,81])
and objective measures [79] of childhood adversity were
adopted by these studies in comparison to those which
found evidence for a gene-environment interaction who
mainly used questionnaires (for example, [74,76]). There
are several possible explanations for these null findings.
The interaction between child adversity and BDNF may
be developmentally sensitive and only manifests later in
life (beyond adolescence). It is also possible that the
BDNF-childhood adversity relationship in depression is a
measurement artefact. Thus, future studies should assess
an adult sample using interviews or objective measures of
child adversity.
Stressful life events
The results of the meta-analysis showed that the effect
of stressful life events on depression is significantly
moderated by the BDNF polymorphism. The majority
of the positive studies measured stressful events using
researcher-administered questionnaires or interviews
while the majority of the non-replicating studies uti-
lised self-report checklists. It is possible that more ob-
jective and sensitive approaches to measuring stressful
life events are required to observe its interaction with
BDNF in depression.
BDNF
The BDNF gene consists of a number of polymorphisms
which may also be relevant for gene-environment inter-
actions in depression [55]. The majority of published
studies have focused BDNF Val66Met, which allows for
the present meta-analysis, but it would be useful for fu-
ture studies to explore the relationship between other
BDNF polymorphisms and stress in depression.
Limitations
The studies reviewed in this article are subject to a number
of limitations. Firstly, different life stress measures were
employed. Questionnaires present the biggest challenge as
they rely on self-report and are vulnerable to various biases
such as the participant’s subjective interpretation of what
counts as an event and enquire about a restricted number
of events. Despite these limitations, most studies relied on
self-report questionnaires, casting doubt on their results.
Some studies have attempted to overcome these problems
by using trained researchers to administer the question-
naires providing some improvement. More robust methods,
such as life stress interviews or use of social services
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combat many of the biases associated with self-report.
Secondly, the majority of included studies used Caucasian
samples, which may have influenced the results. It is
possible that the BDNF × stress in depression is only
relevant to Caucasian populations, although significant
interactions have been reported among Asian [43] and
ethnically mixed populations [76,77]. Future studies need
to recruit participants from non-Caucasian backgrounds
to test the generalisability of the BDNF × stress in depres-
sion to other ethnic groups.
Thirdly, several included studies may have limited power
due to their restricted sample sizes (for example, [65,78]).
For the current study, power analyses revealed that using
the pooled samples provided greater than 80% power to
detect significant effects of all three interactions tested in
this project (these are, (1) life stress × BDNF, (2) child-
hood adversity × BDNF, (3) stressful life events × BDNF
in depression).
Finally, the statistical approach used to conduct the
current meta-analysis relied on combining the P values
of existing studies, which were weighted by sample size.
This approach was adopted to maximise the number of
studies that could be included, with the aim of reducing
biases associated with selecting a homogeneous set of
studies and to better reflect the current evidence in this
field. The meta-analytic method of combining P values
could be improved upon by using traditional approaches
that focus on combining effect sizes, which benefit from
providing the magnitude of an effect.
Conclusions
A total of 22 studies with a pooled sample of 14,233 indi-
viduals were included in this review, of which 8 provided
evidence in support of an interaction between life stress
and the BDNF Val66Met polymorphism in depression. A
meta-analysis provided evidence for an interaction between
the Met variant of the BDNF Val66Met polymorphism and
life stress in the causation of depression. When stratified by
the type of stress, the results of the meta-analyses were only
significant for stressful life events and not childhood adver-
sity. This suggests that serotonin transporter and BDNF
genes may confer sensitivity to early and late environmental
factors respectively and play complementary yet distinct
roles in the depression aetiology.
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